Prevalence of IL28B Polymorphism in Hepatitis C Patients
N/A
Response to peginterferon and ribavirin treatment in hepatitis C (HCV) depe...
Status
Completed
Location
Changi General Hospital
Start Date
2014-06
Trial ID
NCT03415009
A Study Evaluating IL28B Polymorphism in Patients With HBeAg-Negative Chronic Hepatitis B Treated With Pegasys (Peginterferon Alfa-2a) in Study ML18253
PHASE3
This cross-sectional multicenter study will evaluate the IL28B polymorphism...
Status
Completed
Location
Azienda Ospedaliera Policlinico Consorziale di Bari; Clinica Malattie Infettive
A Randomized Trial of 24-Week Versus 48-Week Courses of Peginterferon Plus Ribavirin for Patients With Genotype 1 Hepatitis C and IL28B CC Polymorphism
PHASE3
Patients with HCV genotype 1 and IL28B CC Polymorphism who have a rapid vir...